175 related articles for article (PubMed ID: 22018804)
1. Caspase-6 and neurodegeneration.
Graham RK; Ehrnhoefer DE; Hayden MR
Trends Neurosci; 2011 Dec; 34(12):646-56. PubMed ID: 22018804
[TBL] [Abstract][Full Text] [Related]
2. Activation and regulation of caspase-6 and its role in neurodegenerative diseases.
Wang XJ; Cao Q; Zhang Y; Su XD
Annu Rev Pharmacol Toxicol; 2015; 55():553-72. PubMed ID: 25340928
[TBL] [Abstract][Full Text] [Related]
3. Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice.
Uribe V; Wong BK; Graham RK; Cusack CL; Skotte NH; Pouladi MA; Xie Y; Feinberg K; Ou Y; Ouyang Y; Deng Y; Franciosi S; Bissada N; Spreeuw A; Zhang W; Ehrnhoefer DE; Vaid K; Miller FD; Deshmukh M; Howland D; Hayden MR
Hum Mol Genet; 2012 May; 21(9):1954-67. PubMed ID: 22262731
[TBL] [Abstract][Full Text] [Related]
4. [Caspase activation precedes and leads to neurodegeneration in a murine model of Alzheimer's disease].
de Calignon A; Spires-Jones TL; Hyman BT
Med Sci (Paris); 2010 Oct; 26(10):787-9. PubMed ID: 20929661
[No Abstract] [Full Text] [Related]
5. Identification of the novel substrates for caspase-6 in apoptosis using proteomic approaches.
Cho JH; Lee PY; Son WC; Chi SW; Park BC; Kim JH; Park SG
BMB Rep; 2013 Dec; 46(12):588-93. PubMed ID: 24195789
[TBL] [Abstract][Full Text] [Related]
6. Caspase-6 as a novel early target in the treatment of Alzheimer's disease.
LeBlanc AC
Eur J Neurosci; 2013 Jun; 37(12):2005-18. PubMed ID: 23773070
[TBL] [Abstract][Full Text] [Related]
7. Caspase inhibition: a potential therapeutic strategy in neurological diseases.
Rideout HJ; Stefanis L
Histol Histopathol; 2001 Jul; 16(3):895-908. PubMed ID: 11510981
[TBL] [Abstract][Full Text] [Related]
8. Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches.
Wellington CL; Hayden MR
Clin Genet; 2000 Jan; 57(1):1-10. PubMed ID: 10733228
[TBL] [Abstract][Full Text] [Related]
9. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis. Dead end for neurodegeneration?
Haass C
Nature; 1999 May; 399(6733):204-5, 207. PubMed ID: 10353238
[No Abstract] [Full Text] [Related]
11. Expression of the pro-domain-deleted active form of caspase-6 in Escherichia coli.
Lee PY; Cho JH; Chi SW; Bae KH; Cho S; Park BC; Kim JH; Park SG
J Microbiol Biotechnol; 2014 May; 24(5):719-23. PubMed ID: 24572277
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of caspase-3 by a competitive DARPin: molecular mimicry between native and designed inhibitors.
Schroeder T; Barandun J; Flütsch A; Briand C; Mittl PR; Grütter MG
Structure; 2013 Feb; 21(2):277-89. PubMed ID: 23333429
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acids.
Vickers CJ; González-Páez GE; Litwin KM; Umotoy JC; Coutsias EA; Wolan DW
ACS Chem Biol; 2014 Oct; 9(10):2194-8. PubMed ID: 25079698
[TBL] [Abstract][Full Text] [Related]
14. An optimized activity-based probe for the study of caspase-6 activation.
Edgington LE; van Raam BJ; Verdoes M; Wierschem C; Salvesen GS; Bogyo M
Chem Biol; 2012 Mar; 19(3):340-52. PubMed ID: 22444589
[TBL] [Abstract][Full Text] [Related]
15. Identification of Allosteric Inhibitors against Active Caspase-6.
Tubeleviciute-Aydin A; Beautrait A; Lynham J; Sharma G; Gorelik A; Deny LJ; Soya N; Lukacs GL; Nagar B; Marinier A; LeBlanc AC
Sci Rep; 2019 Apr; 9(1):5504. PubMed ID: 30940883
[TBL] [Abstract][Full Text] [Related]
16. Caspase-9 Activation of Procaspase-3 but Not Procaspase-6 Is Based on the Local Context of Cleavage Site Motifs and on Sequence.
Soni IV; Hardy JA
Biochemistry; 2021 Sep; 60(37):2824-2835. PubMed ID: 34472839
[TBL] [Abstract][Full Text] [Related]
17. Anamorsin, a novel caspase-3 substrate in neurodegeneration.
Yun N; Lee YM; Kim C; Shibayama H; Tanimura A; Hamanaka Y; Kanakura Y; Park IS; Jo A; Shin JH; Ju C; Kim WK; Oh YJ
J Biol Chem; 2014 Aug; 289(32):22183-95. PubMed ID: 24973211
[TBL] [Abstract][Full Text] [Related]
18. Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding.
Dagbay KB; Bolik-Coulon N; Savinov SN; Hardy JA
J Biol Chem; 2017 Mar; 292(12):4885-4897. PubMed ID: 28154009
[TBL] [Abstract][Full Text] [Related]
19. Interactome network analysis identifies multiple caspase-6 interactors involved in the pathogenesis of HD.
Riechers SP; Butland S; Deng Y; Skotte N; Ehrnhoefer DE; Russ J; Laine J; Laroche M; Pouladi MA; Wanker EE; Hayden MR; Graham RK
Hum Mol Genet; 2016 Apr; 25(8):1600-18. PubMed ID: 26908611
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes.
Duran-Vilaregut J; Del Valle J; Manich G; Junyent F; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Neurochem Int; 2010 Feb; 56(3):443-50. PubMed ID: 19969037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
